dimethyltryptamine.eth Buys $206.5K PEPE Amid Market Turmoil
A significant PEPE purchase was made by the address dimethyltryptamine.eth during a market downturn.
A significant PEPE purchase was made by the address dimethyltryptamine.eth during a market downturn. Pepe (PEPE) is trading at ₹0.000492 ($0.00000516), up 5.3% since this brief published. This is an original Token Times brief based on reporting by Coinfomania, with live market data added, as of Fri, 30 Oct 2026 11:00:01 UTC.
This large purchase during a market downturn signals potential investor confidence in PEPE, despite recent negative market sentiment and a major sell-off triggered by a Binance hack.
- dimethyltryptamine.eth purchased 45.08 billion PEPE tokens for $206.5K.
- The purchase occurred amid a market downturn and post-Binance hack sell-off.
- PEPE's market cap remains at $2.06B despite the recent volatility.
In a bold move during a period of market uncertainty, the 
Ethereum address dimethyltryptamine.eth has purchased 45.08 billion PEPE tokens, valued at approximately $206.5K. This transaction took place amidst a broader market downturn and was catalyzed by a significant sell-off following a security incident at Binance.
The purchase highlights a potential vote of confidence in the PEPE token, which has seen its market cap remain resilient at $2.06 billion despite the recent volatility. The token's price has experienced a slight decline of 1.27% over the past 24 hours but remains up 0.23% over the last seven days.
The broader cryptocurrency market continues to face downward pressure, with 
Bitcoin down 3.16% in the last 24 hours and the overall market cap shrinking to $2.67 trillion. The Fear & Greed Index currently stands at 30, indicating a sentiment of 'Fear' among investors.
This transaction is notable as it suggests that some investors may view the recent market turbulence as a buying opportunity. The address's sizable purchase could be seen as a strategic move to accumulate tokens at a perceived discount.
Since this brief published about 56 minutes ago, Pepe (PEPE) has moved from ₹0.000467$0.0000049 to ₹0.000492$0.00000516 — +5.31%, a notable move.
The chart plots PEPE's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution; intraday detail builds over the first day). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 PEPE ≈ ₹0.000543 (about $0.00000516), up 6.4% over 24 hours. The rupee itself trades about 10.4% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the assets in this story — live, source-stamped, updated every 15 minutes.
dimethyltryptamine.eth Buys $206.5K PEPE Amid Market Turmoil — questions & answers
What is the total value of the PEPE purchase?
The purchase was valued at approximately $206.5K.
Why did the PEPE purchase happen?
It occurred during a market downturn following a Binance hack, suggesting a possible contrarian investment strategy.
How much PEPE did dimethyltryptamine.eth buy?
The address purchased 45.08 billion PEPE tokens.
How much is 1 Pepe worth in rupee today?
About ₹0.000543 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $0.00000516. The rupee price moves with both PEPE's US-dollar price and the USDT/INR rate; use our Pepe in rupee page for any amount.
Has Pepe's price moved since this brief was published?
PEPE is up 5.31% since this brief first published — trading at ₹0.000492 ($0.00000516) now versus ₹0.000467 ($0.0000049) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Coinfomania. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.